ALVO

Alvotech

9.15 USD

Last updated Dec 9, 14:37 UTC

Yesterday HIGH

$9.58

Yesterday LOW

$9.08

52w HIGH

$14.6

52w LOW

$6.28

EPS

-0.82

PE

-11.16

Next Earnings

Aug 30, 2023

Overview News Government Trades

Alvotech stock is up 5.29% since 30 days ago. The next earnings date is Aug 30, 2023. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 3 December’s closed higher than November.

N/A

Stock Exchange

NASDAQ

Sector

Manufacturing

Industry

Pharmaceutical Products

Headquarters

-

Website

Benzinga Insights

Tue Jul 4, 2023

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights

Mon Jul 3, 2023

12 Health Care Stocks Moving In Monday's Pre-Market Session
Lisa Levin

Fri Jun 30, 2023

Why Cineverse Shares Are Trading Lower By 18%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Gainers Addentax Group Corp. (NASDAQ: ATXG) shares jumped 47.3% to $9.68. Addentax Group is launching automation of artificial intelligence internet operational tools project with top Games-as-a-Service firms.
Lisa Levin

Fri Jun 30, 2023

Carnival, SMART Global, Friedman Industries And Other Big Stocks Moving Higher On Friday

U.S. stocks traded higher, with the Dow Jones gaining more than 200 points on Friday. Here are some big stocks recording gains in today’s session.
Benzinga Insights

Fri Jun 30, 2023

12 Health Care Stocks Moving In Friday's Pre-Market Session
Lisa Levin

Thu Jun 29, 2023

BioXcel Therapeutics, Alvotech And Other Big Stocks Moving Lower On Thursday

U.S. stocks traded higher, with the Dow Jones gaining around 200 points on Thursday. Here are some big stocks recording losses in today’s session.
Benzinga Newsdesk

Thu Jun 29, 2023

Late Wednesday, The FDA Issued A Complete Response Letter To Alvotech's Second Application For AVT02, A Biosimilar Candidate For Humira (Adalimumab); The Letter Noted Certain Deficiencies Regarding The Reinspection Of Its Reykjavik Facility

As the second of two BLAs submitted for AVT02, this BLA contained data to support approval as a high-concentration biosimilar and additional information to support the interchangeability designation.
Benzinga Newsdesk

Mon Jun 12, 2023

Alvotech, Teva Secure US License Date For AVT04, A Proposed Biosimilar To Stelara; Reach Settlement And License Agreement With Johnson & Johnson Concerning AVT04
Benzinga Newsdesk

Wed May 24, 2023

Alvotech, Advanz Pharma Extend Strategic Partnership To Commercialize Five Proposed Biosimilars In Europe

Alvotech will be responsible for development and commercial supply and Advanz Pharma will be responsible for registration and commercialization in Europe.
Lisa Levin

Tue May 23, 2023

BJ's Wholesale, Kingsoft Cloud, Zoom Video And Other Big Stocks Moving Lower On Tuesday

U.S. stocks traded mixed, with the Nasdaq Composite dropping around 30 points on Tuesday. Here are some big stocks recording losses in today’s session.

TECS $10.99 USD

EXTR $17.02 USD

ALXO $12.31 USD

AMBC $16.40 USD

IYW $118.24 USD

SRUUF SRUUF $0.00 USD

BITW BITW $0.00 USD

RVLV $15.48 USD